Myocarditis and pericarditis after mRNA COVID-19 vaccination

i

Myocarditis and pericarditis after mRNA COVID-19 vaccination

Multi-Language Supporting Files Public Domain

Sept. 12, 2023
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

File Language:

Details

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Sept. 12, 2023

COVID-19 vaccine recommendations have been updated as of October 3, 2023 to add 2023-2024 updated Novavax COVID-19 vaccine. The content on this page will be updated to align with the new recommendations. Learn more.

CDC and its partners are actively monitoring reports of myocarditis and pericarditis after COVID-19 vaccination. Active monitoring includes reviewing data and medical records and evaluating the relationship to COVID-19 vaccination.
Subjects:

Cardiovascular Diseases COVID-19 Vaccines/adverse Effects COVID-19/prevention & Control Myocarditis Pericarditis
Document Type:

Webpage
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:e44db71ede807b8783c372c93b09980bd803e77097d00c7e3acef27a28f65e5f
Download URL:

https://stacks.cdc.gov/view/cdc/134111/cdc_134111_DS1.pdf
File Type:

[PDF - 315.38 KB ]

myocarditis.html

html

File Language:

ON THIS PAGE

Details Supporting Files

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.